Clinical Trials in New York State

Showing 3281-3300 of 8,190 trials

COmbination Therapy With Baloxavir and Oseltamivir 1 for Hospitalized Patients With Influenza (The COMBO Trial 1)

NCT04327791

This is a randomized, double-blind, placebo-controlled Phase 2-like, investigator-directed trial of hospitalized patients with laboratory confirmed influenza. Eligible and consented patients will be randomly assigned, in a 1:1 ratio, to one of two groups: Group 1, the combination treatment group (oseltamivir and baloxavir); Group 2, the standard treatment group (oseltamivir and placebo).

Influenza

Bassett Healthcare60 participantsStarted Apr 2020

Springfield, Massachusetts, United States • Cooperstown, New York, United States • Portland, Oregon, United States

COMPLETEDPhase 269 miles

Dinutuximab in Combination With Sargramostim in Treating Patients With Recurrent Osteosarcoma

NCT02484443

This phase II trial studies how well dinutuximab works when given with sargramostim in treating patients with osteosarcoma that has come back after treatment (recurrent). Monoclonal antibodies, such as dinutuximab, may find tumor cells and help kill them. Sargramostim may help the body increase the amount of white blood cells it produces, which help the body fight off infections. Giving dinutuximab with sargramostim may work better and kill more cancer cells.

Metastatic Malignant Neoplasm in the LungMetastatic OsteosarcomaRecurrent Osteosarcoma

National Cancer Institute (NCI)41 participantsStarted Feb 2016

Birmingham, Alabama, United States • Phoenix, Arizona, United States • Little Rock, Arkansas, United States +127 more locations

COmbination Therapy With Baloxavir and Oseltamivir 1 for Hospitalized Patients With Influenza (The COMBO Trial 1)

Dinutuximab in Combination With Sargramostim in Treating Patients With Recurrent Osteosarcoma

Find Trials by Condition in New York State

Flecainide Acetate Inhalation Solution for Cardioversion of Recent-Onset, Symptomatic Atrial Fibrillation

A Study to Investigate Atezolizumab and Chemotherapy Compared With Placebo and Chemotherapy in the Neoadjuvant Setting in Participants With Early Stage Triple Negative Breast Cancer

Study to Assess the Safety and Efficacy of Ribociclib (LEE011) in Combination With Letrozole for the Treatment of Men and Pre/Postmenopausal Women With HR+ HER2- aBC

A Study of MEK162 vs. Physician's Choice Chemotherapy in Patients With Low-grade Serous Ovarian, Fallopian Tube or Peritoneal Cancer

Trial to Evaluate the Efficacy and Safety of Abatacept in Combination With Standard Therapy Compared to Standard Therapy Alone in Improving Disease Activity in Adults With Active Idiopathic Inflammatory Myopathy

Triage Survey for Psychiatry Research Eligibility

A Study of BMS-986166 or Branebrutinib for the Treatment of Participants With Atopic Dermatitis

A Study to Compare the Efficacy of Arfolitixorin Versus Leucovorin in Combination With 5 Fluorouracil, Oxaliplatin, and Bevacizumab in Patients With Advanced Colorectal Cancer

A Study of ARRY-502 in Patients With Persistent Asthma

A Study Evaluating the Safety, Pharmacokinetics and Efficacy of Ipatasertib Administered in Combination With Rucaparib in Participants With Advanced Breast, Ovarian Cancer, and Prostate Cancer.

A Study to Evaluate the Safety and Tolerability of ABBV-951 in Subjects With Parkinson's Disease (PD)

Nano-Pulse Stimulation (NPS) in Seborrheic Keratosis Optimization Study

A Study of HB0045 Injection in Patients With Advanced Solid Tumors

A Study of CodaLytic, an Intratumoral Oncolytic Virus, in Patients With Breast Cancer

Study of the ConforMIS iDuo(R) G2

A Prospective, Multicenter Study to Evaluate the ConforMIS iTotal® (CR) Knee Replacement System

Dual Focus Soft Contact Lens Wear Cessation Study

Exacerbations and Their Outcomes International (EXACOS International)